|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,399.50 JPY | +2.02% |
|
+5.98% | +19.86% |
| Feb. 05 | Mitsui Chemicals, Inc. authorizes a Buyback Plan. | CI |
| Feb. 05 | Mitsui Chemicals, Inc. announces an Equity Buyback for 18,400,000 shares, representing 4.89% for ¥30,000 million. | CI |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.34 | 4.75 | 2.83 | 2.51 | 2.68 | |||||
Return on Total Capital | 4.31 | 6.23 | 3.66 | 3.19 | 3.39 | |||||
Return On Equity % | 9.96 | 15.92 | 10.66 | 5.76 | 4.36 | |||||
Return on Common Equity | 10.19 | 16.66 | 11.06 | 6.06 | 3.77 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 24.25 | 23.48 | 20.3 | 21.19 | 21.46 | |||||
SG&A Margin | 13.67 | 11.68 | 12.01 | 12.62 | 12.81 | |||||
EBITDA Margin % | 13.02 | 13.45 | 9.73 | 10.35 | 10.68 | |||||
EBITA Margin % | 6.7 | 8.23 | 4.83 | 4.91 | 5.17 | |||||
EBIT Margin % | 6.7 | 8.23 | 4.83 | 4.91 | 5.17 | |||||
Income From Continuing Operations Margin % | 5.3 | 7.35 | 4.8 | 3.07 | 2.36 | |||||
Net Income Margin % | 4.78 | 6.82 | 4.41 | 2.86 | 1.78 | |||||
Net Avail. For Common Margin % | 4.78 | 6.82 | 4.41 | 2.86 | 1.78 | |||||
Normalized Net Income Margin | 3.92 | 5.68 | 3.23 | 3.37 | 2.86 | |||||
Levered Free Cash Flow Margin | 6.39 | -6.29 | -4.34 | -1.84 | 3.78 | |||||
Unlevered Free Cash Flow Margin | 6.64 | -6.13 | -4.14 | -1.55 | 4.07 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.8 | 0.92 | 0.94 | 0.82 | 0.83 | |||||
Fixed Assets Turnover | 2.45 | 3.06 | 3.26 | 2.79 | 2.74 | |||||
Receivables Turnover (Average Receivables) | 4.35 | 4.91 | 5.2 | 4.87 | 5.06 | |||||
Inventory Turnover (Average Inventory) | 3.36 | 3.93 | 3.69 | 3.09 | 3.18 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.69 | 1.46 | 1.57 | 1.74 | 1.72 | |||||
Quick Ratio | 1.04 | 0.8 | 0.8 | 0.89 | 0.89 | |||||
Operating Cash Flow to Current Liabilities | 0.37 | 0.13 | 0.15 | 0.24 | 0.33 | |||||
Days Sales Outstanding (Average Receivables) | 83.99 | 74.27 | 70.16 | 75.1 | 72.16 | |||||
Days Outstanding Inventory (Average Inventory) | 108.72 | 92.85 | 98.79 | 118.51 | 114.81 | |||||
Average Days Payable Outstanding | 50.96 | 39.99 | 39.39 | 45.38 | 43.63 | |||||
Cash Conversion Cycle (Average Days) | 141.75 | 127.13 | 129.56 | 148.23 | 143.34 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 74.79 | 82.53 | 83.58 | 76.84 | 76.03 | |||||
Total Debt / Total Capital | 42.79 | 45.21 | 45.53 | 43.45 | 43.19 | |||||
LT Debt/Equity | 43.02 | 39.58 | 41.86 | 43.93 | 46.93 | |||||
Long-Term Debt / Total Capital | 24.61 | 21.69 | 22.8 | 24.84 | 26.66 | |||||
Total Liabilities / Total Assets | 56.22 | 58.29 | 57.29 | 55.56 | 54.94 | |||||
EBIT / Interest Expense | 16.86 | 32.52 | 14.93 | 10.92 | 10.98 | |||||
EBITDA / Interest Expense | 32.79 | 53.14 | 30.08 | 23.03 | 22.7 | |||||
(EBITDA - Capex) / Interest Expense | 17.22 | 26.92 | 8.3 | 4.71 | 8.47 | |||||
Total Debt / EBITDA | 3.23 | 3.07 | 4.04 | 4.18 | 3.82 | |||||
Net Debt / EBITDA | 1.99 | 2.23 | 3.02 | 3.02 | 2.94 | |||||
Total Debt / (EBITDA - Capex) | 6.16 | 6.06 | 14.63 | 20.41 | 10.24 | |||||
Net Debt / (EBITDA - Capex) | 3.79 | 4.41 | 10.94 | 14.74 | 7.87 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -9.5 | 33.09 | 16.55 | -6.91 | 3.4 | |||||
Gross Profit, 1 Yr. Growth % | -1.11 | 28.89 | 0.73 | -2.8 | 4.72 | |||||
EBITDA, 1 Yr. Growth % | 30.33 | 37.55 | -15.75 | -0.91 | 6.71 | |||||
EBITA, 1 Yr. Growth % | 16.61 | 63.65 | -31.66 | -5.33 | 8.89 | |||||
EBIT, 1 Yr. Growth % | 17.7 | 63.65 | -31.66 | -5.33 | 8.89 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 38.73 | 84.6 | -23.97 | -40.34 | -20.73 | |||||
Net Income, 1 Yr. Growth % | 52.52 | 90.05 | -24.6 | -39.71 | -35.51 | |||||
Normalized Net Income, 1 Yr. Growth % | 45.79 | 92.69 | -33.65 | -2.87 | -12.36 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 52.87 | 89.75 | -23.75 | -39.01 | -35.14 | |||||
Accounts Receivable, 1 Yr. Growth % | 5.16 | 29.59 | -4.93 | 3.89 | -4.49 | |||||
Inventory, 1 Yr. Growth % | -10.14 | 42.58 | 19.77 | 2.06 | -1.84 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 3.38 | 10.28 | 8.54 | 8.52 | 2.63 | |||||
Total Assets, 1 Yr. Growth % | 5.27 | 24.19 | 6.89 | 7.14 | -2.79 | |||||
Tangible Book Value, 1 Yr. Growth % | 17.74 | 10.6 | 10.78 | 9.33 | -3.24 | |||||
Common Equity, 1 Yr. Growth % | 15.23 | 17.23 | 10.41 | 9.66 | -1.69 | |||||
Cash From Operations, 1 Yr. Growth % | 51.62 | -46.89 | 9.35 | 59.36 | 24.27 | |||||
Capital Expenditures, 1 Yr. Growth % | 4.18 | 42.94 | 23.61 | 8.86 | -15.86 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 271.44 | -230.9 | -19.57 | -60.6 | -312.92 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 231.24 | -222.84 | -21.34 | -65 | -370.95 | |||||
Dividend Per Share, 1 Yr. Growth % | 0 | 15 | 4.35 | 16.67 | 7.14 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -9.6 | 9.75 | 24.54 | 4.16 | -1.89 | |||||
Gross Profit, 2 Yr. CAGR % | -3.62 | 12.9 | 13.94 | -1.05 | 0.89 | |||||
EBITDA, 2 Yr. CAGR % | 5.06 | 33.89 | 7.65 | -8.63 | 2.83 | |||||
EBITA, 2 Yr. CAGR % | -7.14 | 38.14 | 5.75 | -19.56 | 1.53 | |||||
EBIT, 2 Yr. CAGR % | -6.81 | 38.78 | 5.75 | -19.56 | 1.53 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -13.85 | 60.03 | 18.47 | -32.65 | -31.23 | |||||
Net Income, 2 Yr. CAGR % | -12.8 | 70.26 | 19.71 | -32.58 | -37.65 | |||||
Normalized Net Income, 2 Yr. CAGR % | -6.14 | 67.61 | 13.07 | -19.72 | -7.74 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -12.09 | 70.32 | 20.29 | -31.8 | -37.11 | |||||
Accounts Receivable, 2 Yr. CAGR % | -3.96 | 16.74 | 11 | -0.61 | -0.38 | |||||
Inventory, 2 Yr. CAGR % | -7.41 | 13.19 | 30.67 | 10.56 | 0.09 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 6.44 | 6.78 | 9.41 | 8.53 | 5.53 | |||||
Total Assets, 2 Yr. CAGR % | 1.88 | 14.34 | 15.21 | 7.01 | 2.05 | |||||
Tangible Book Value, 2 Yr. CAGR % | 6 | 14.11 | 10.69 | 10.05 | 2.85 | |||||
Common Equity, 2 Yr. CAGR % | 4.95 | 16.22 | 13.77 | 10.03 | 3.83 | |||||
Cash From Operations, 2 Yr. CAGR % | 26.18 | -10.26 | -23.79 | 32.01 | 40.73 | |||||
Capital Expenditures, 2 Yr. CAGR % | 18.67 | 22.03 | 32.92 | 16 | -4.3 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 22.21 | 120.51 | 2.61 | -43.71 | -8.41 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 20.61 | 101.71 | -1.7 | -47.53 | -2.61 | |||||
Dividend Per Share, 2 Yr. CAGR % | 0 | 7.24 | 9.54 | 10.34 | 11.8 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -3.02 | 2.84 | 11.97 | 13.03 | 3.91 | |||||
Gross Profit, 3 Yr. CAGR % | -1.7 | 6.19 | 8.69 | 8.06 | 0.83 | |||||
EBITDA, 3 Yr. CAGR % | 1.89 | 14.93 | 14.73 | 4.72 | -3.78 | |||||
EBITA, 3 Yr. CAGR % | -8.04 | 12.17 | 9.25 | 1.92 | -11.02 | |||||
EBIT, 3 Yr. CAGR % | -7.8 | 12.43 | 9.59 | 1.92 | -11.02 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -6.68 | 11.07 | 24.88 | -5.74 | -28.89 | |||||
Net Income, 3 Yr. CAGR % | -6.84 | 13.06 | 29.78 | -4.76 | -33.57 | |||||
Normalized Net Income, 3 Yr. CAGR % | -8.2 | 19.29 | 23.07 | 7.49 | -17.34 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -5.96 | 13.61 | 30.29 | -4.08 | -32.94 | |||||
Accounts Receivable, 3 Yr. CAGR % | -2.27 | 6.13 | 9.02 | 8.58 | -1.92 | |||||
Inventory, 3 Yr. CAGR % | -1.92 | 6.92 | 15.34 | 20.34 | 6.26 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 5.06 | 7.71 | 7.36 | 9.11 | 6.53 | |||||
Total Assets, 3 Yr. CAGR % | 2.57 | 8.83 | 11.8 | 12.45 | 3.64 | |||||
Tangible Book Value, 3 Yr. CAGR % | 6.97 | 7.51 | 12.99 | 10.23 | 5.43 | |||||
Common Equity, 3 Yr. CAGR % | 5.95 | 8.89 | 14.25 | 12.38 | 5.98 | |||||
Cash From Operations, 3 Yr. CAGR % | 28.24 | -5.44 | -4.15 | -2.55 | 29.38 | |||||
Capital Expenditures, 3 Yr. CAGR % | 14.74 | 26.26 | 22.56 | 24.36 | 4.22 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 91.51 | 25.04 | 57.55 | -25.42 | -12.29 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 77.24 | 21.35 | 47.37 | -30.33 | -9.3 | |||||
Dividend Per Share, 3 Yr. CAGR % | 3.57 | 4.77 | 6.27 | 11.87 | 9.26 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -2.05 | 5.87 | 7.19 | 3.36 | 6.2 | |||||
Gross Profit, 5 Yr. CAGR % | 1.38 | 5.27 | 4.28 | 3.23 | 5.5 | |||||
EBITDA, 5 Yr. CAGR % | 5.7 | 8.42 | 4.15 | 4.85 | 9.82 | |||||
EBITA, 5 Yr. CAGR % | 1.83 | 5.41 | -2.75 | -1.8 | 6.1 | |||||
EBIT, 5 Yr. CAGR % | 2.72 | 5.67 | -2.6 | -1.67 | 6.3 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 16.86 | 9.93 | 2.67 | -9.07 | -1.63 | |||||
Net Income, 5 Yr. CAGR % | 20.31 | 11.15 | 2.99 | -8.06 | -3.2 | |||||
Normalized Net Income, 5 Yr. CAGR % | 7.58 | 12.1 | -0.22 | 1.82 | 9.67 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 21.03 | 11.78 | 3.77 | -7.37 | -2.64 | |||||
Accounts Receivable, 5 Yr. CAGR % | 3.17 | 6.44 | 2.84 | 3.38 | 5.15 | |||||
Inventory, 5 Yr. CAGR % | 1.46 | 8.31 | 10.01 | 8.36 | 8.98 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 3.96 | 6.22 | 6.78 | 8.04 | 6.63 | |||||
Total Assets, 5 Yr. CAGR % | 4.36 | 7.86 | 7.45 | 8.1 | 7.79 | |||||
Tangible Book Value, 5 Yr. CAGR % | 11.43 | 9.39 | 8.44 | 8.52 | 8.82 | |||||
Common Equity, 5 Yr. CAGR % | 9.74 | 9.65 | 9.01 | 9.35 | 9.96 | |||||
Cash From Operations, 5 Yr. CAGR % | 3.62 | -1.62 | 4.14 | 8.06 | 11.76 | |||||
Capital Expenditures, 5 Yr. CAGR % | 13.34 | 22.05 | 21.69 | 22.05 | 11.01 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -11.19 | 18.26 | 49.21 | -9.13 | 26.82 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -11.03 | 15.82 | 40.01 | -13.23 | 24.87 | |||||
Dividend Per Share, 5 Yr. CAGR % | 20.11 | 13.9 | 5.92 | 6.96 | 8.45 |
- Stock Market
- Equities
- 4183 Stock
- Financials Mitsui Chemicals, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















